A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 58, Issue 5, 2014, Pages 632-636

  Nobili, Valerio ^a   Donati, Benedetta ^b   Panera, Nadia ^a   Vongsakulyanon, Apirom ^b   Alisi, Anna ^a   Dallapiccola, Bruno ^a   Valenti, Luca ^b  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

children; genetics; hepatic fibrosis; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TRIACYLGLYCEROL; ADIPONUTRIN, HUMAN; KLF6 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; LPIN1 PROTEIN, HUMAN; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE PROTEIN; ONCOPROTEIN; PHOSPHATIDATE PHOSPHATASE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL LIPASE;

ADOLESCENT; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; GENE; GENETIC ANALYSIS; GENETIC RISK; GENETIC RISK SCORE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; KLF6 GENE; LIVER BIOPSY; LPIN1 GENE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PNPLA3 GENE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOD2 GENE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT; BIOPSY; COMPLICATION; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; STATISTICAL MODEL;

ADOLESCENT; BIOPSY; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIPASE; LIVER; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHOSPHATIDATE PHOSPHATASE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; ROC CURVE; SUPEROXIDE DISMUTASE;

EID: 84900417152     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000279     Document Type: Article

References (19)

1. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007;45:846-54.
2. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010;52: 1836-46.
3. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 2010;5:145-71.
4. Dam-Larsen S, Franzmann M, Andersen IB, et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 2004; 53:750-5.
5. Yilmaz Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 2012;36:815-23.
6. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, et al. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 2009;58:1538-44.
7. Al-Serri A, Anstee QM, Valenti L, et al. The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies. J Hepatol 2012;56:448-54.
8. Valenti L, Alisi A, Galmozzi E, et al. I148 M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 2010;52:1274-80.
9. Valenti L, Motta BM, Alisi A, et al. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2012;5:588-93.
10. Dongiovanni P, Valenti L, Rametta R, et al. Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut 2010; 59:267-73.
11. Miele L, Beale G, Patman G, et al. The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenter-ology 2008;135:282-91.
12. Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008;40:1461-5.
13. Yuan X, Waterworth D, Perry JR, et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 2008;83:520-8.
14. Sookoian S, Castano GO, Burgueno AL, et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res 2009;50:2111-6.
15. Valenti L, Al-Serri A, Daly AK, et al. Homozigosity for the PNPLA3/adiponutrin I148 M polymorphism influences liver fibrosis in patients with non alcoholic fatty liver disease. Hepatology 2010;51:1209-17.
16. Reue K. The lipin family: mutations and metabolism. Curr Opin Lipidol 2009;20:165-70.
17. Fawcett KA, Grimsey N, Loos RJ, et al. Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. populations. Diabetes 2008;57:2527-33.
18. Viganò M, Valenti L, Lampertico P, et al. PNPLA3 I148 M affects liver steatosis in patients with chronic hepatitis B. Hepatology 2013;58: 1245-52.
19. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepa-tology 2005;41:1313-21.